INS and diabetes mellitus: FTY720, an S1P1 modulator [24] which has been shown to prevent diabetes in NOD mice and islet rejection [29], [30], prevented loss of insulin+ cells, T cell infiltration and lymphangiogenesis, demonstrating that lymphangiogenesis is involved in islet inflammation.